老年与年轻患者经蝶窦入路垂体腺瘤切除术:系统综述与荟萃分析
该系统综述与荟萃分析检索PubMed和Medline,评估年龄大于或小于65、70、80岁人群经蝶窦切除术的结局。年轻组总体切除率中位数70.7%,老年组65.7%,差异无统计学意义(p=0.35);仅全切率在小于80岁组更优(p=0.01)。复发率无显著差异,视力改善在大于80岁组更优(p=0.03),总体并发症率在小于70岁组更优(p<0.05)。
要点
- 全切率在小于80岁组更优(p=0.01),总体切除率中位数年轻组70.7% vs 老年组65.7%(p=0.35)。
- 复发率在各年龄组间无显著差异。
- 视力改善在大于80岁组更优(p=0.03),总体并发症率在小于70岁组更优(p<0.05)。
核心结论
- 现有数据显示全切率在年轻患者中更优。
- 平均随访期内复发率相似。
- 视力改善在大于80岁患者中更优。
- 总体并发症率在小于70岁患者中更优,可能与老年人常合并其他疾病有关。
- 经蝶窦手术对老年患者也是安全有效的。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed和Medline数据库发表的英文系列研究,无时间范围限制,评估年龄大于或小于65、70、80岁人群经蝶窦切除术的结局。
主要发现
- 年轻人群总体切除率中位数为70.7%(范围54-76.8),老年人群为65.7%(范围16.6-78.2)(两样本t检验,p=0.35)。
- 全切率(GTR)唯一有统计学显著差异的是小于80岁组更优(p=0.01)。
- 复发率在各年龄组间无统计学显著差异。
- 视力改善在大于80岁组更优,有统计学显著差异(p=0.03)。
- 对于年龄小于70岁与大于70岁组,总体并发症率在年轻组更优,有统计学显著差异(p<0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Pituitary adenomas (PA) are common intracranial tumors. In the context of the aging of the population, the question is whether postsurgical outcomes are comparable to the younger ones. The primary objective of the present study was to review published resection and recurrence rates after transsphenoidal resection. The secondary aim was to evaluate visual improvement and complication rates. METHODS: The authors searched PubMed and Medline databases, of published English series, with no time frame limit, evaluating outcomes of transsphenoidal resection in populations aged more or less than 65, 70, and 80 years. We performed a systematic review and meta-analysis. RESULTS: Median overall resection rates for younger population was 70.7% (range 54-76.8) and for elderly one was 65.7% (range 16.6-78.2) (two-sample t test, p = 0.35). The only statistically significant difference for gross total resection rates (GTR) favored patients aged less than 80 (p = 0.01). There was no statistically significant difference among recurrence rates. There was a statistically significant difference for visual improvement favoring patients aged more than 80 (p = 0.03). For the age groups of less versus more than 70, there was a statistically significant difference for overall complication rate favoring younger groups (p < 0.05). CONCLUSION: Present data shows GTR rates favoring younger patients. Recurrence rates remain similar over the mean follow-up period. Moreover, visual improvement favors patients aged more than 80. Overall complication rates favor patients younger than 70, which might be also related to additional comorbidities, frequently present in seniors. Transsphenoidal surgery is safe and effective even for older patients.
引用
- Tuleasca C, Ducos Y, Leroy HA, et al. Transsphenoidal resection for pituitary adenoma in elderly versus younger patients: a systematic review and meta-analysis. Acta Neurochir (Wien). 2020. PMID: 32221730. doi:10.1007/s00701-020-04300-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。